Safety study of an investigational injection in healthy adults
This study tests a new injection called GenSci164 in healthy adults. It helps find out how the drug works in the body and if it is safe. Participants receive the injection and are monitored for effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You need to weigh at least 45 kg if female, or 50 kg if male, with a body mass index between 18 and 30.
- You should be in good health, with no significant medical conditions like heart, liver, or kidney problems.
- You must agree to use effective contraception if you or your partner can become pregnant, and not plan to have children during the study and for 3 months after.
- Pregnant or breastfeeding women cannot participate.
- You should not have allergies to the study drug or its components, and no significant allergies to other drugs, foods, or substances.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new injectable medication (GenSci155) that affects growth and metabolism. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in patients with medical conditions.
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This study tests a new drug called GenSci120, given as multiple injections under the skin, to see if it is safe in healthy adults. It will also measure how the drug moves through the body and how it affects certain immune markers.
Hear when a new Healthy Adult Trial Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.